EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
Author:
Funder
National Natural Science Foundation of China
Wuhan Municipal Science and Technology Bureau
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference46 articles.
1. Cancer statistics, 2018;Siegel;CA Cancer J Clin.,2018
2. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy;Wang;Int J Oncol.,2018
3. Recent advances of highly selective CDK4/6 inhibitors in breast cancer;Xu;J Hematol Oncol.,2017
4. Recent advances of bispecific antibodies in solid tumors;Yu;J Hematol Oncol.,2017
5. Current landscape of targeted therapies for hormone-receptor positive, HER2 negative metastatic breast cancer;Ballinger;Front Oncol.,2018
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases;Signal Transduction and Targeted Therapy;2023-11-13
2. EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance;Molecular Cancer;2023-09-30
3. Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management;Frontiers in Medicine;2023-06-02
4. The value of EYA1/3/4 in clear cell renal cell carcinoma: a study from multiple databases;Scientific Reports;2023-05-08
5. The value of EYA1/3/4 in Clear Cell Renal Cell Carcinoma: a study from multiple databases;2023-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3